학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 11건 | 목록 1~20
Academic Journal
Clin Cancer Res
Clinical cancer research, 27 (20
2021, ' Niraparib for advanced breast cancer with germline BRCA1 and BRCA2 mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO study ', Clinical Cancer Research . https://doi.org/10.1158/1078-0432.CCR-21-0310
Academic Journal
Geyer CE Jr; NRG Oncology/NSABP Foundation, Pittsburgh; Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh.; Garber JE; Dana-Farber Cancer Institute, Harvard Medical School, Boston.; Gelber RD; Dana-Farber Cancer Institute, Harvard Medical School, Boston; Harvard T.H. Chan School of Public Health, Boston; Frontier Science Foundation, Boston.; Yothers G; NRG Oncology/NSABP Foundation, Pittsburgh; Department of Biostatistics, University of Pittsburgh, Pittsburgh, USA.; Taboada M; Oncology Biometrics Department, AstraZeneca, Macclesfield.; Ross L; Department of Data Management, Frontier Science (Scotland), Kincraig, Scotland, UK.; Rastogi P; NRG Oncology/NSABP Foundation, Pittsburgh; Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh.; Cui K; Department of Oncology R&D, AstraZeneca, Gaithersburg, USA.; Arahmani A; Research Operations Department, Breast International Group, Brussels, Belgium.; Aktan G; Global Oncology Clinical Development, Merck and Co. Inc., Rahway, USA.; Armstrong AC; Department of Medical Oncology, The Christie Hospital NHS Foundation Trust Manchester, UK.; Arnedos M; European Organisation for Research and Treatment (EORTC), Brussels, Belgium; The Department of Medical Oncology, Institut Bergonie, Bordeaux, France.; Balmaña J; Medical Oncology Department, Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona, Spain.; Bergh J; Department of Oncology-Pathology, Swedish Breast Cancer Group, Karolinska Institute and Breast Cancer Center, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.; Bliss J; Department of Clinical Trials and Statistics Unit (ICR-CTSU), The Institute of Cancer Research, London, UK.; Delaloge S; Department of Cancer Medicine, Institute Gustave Roussy and Unicancer Breast Group, Paris, France.; Domchek SM; Department of Medicine, Basser Center for BRCA at the Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.; Eisen A; Odette Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada.; Elsafy F; Oncology Biometrics Department, AstraZeneca, Macclesfield.; Fein LE; Department of Clinical Research, Instituto de Oncologia De Rosario, Santa Fe, Argentina.; Fielding A; Department of Oncology R&D, AstraZeneca, Gaithersburg, USA.; Ford JM; Department of Medicine/Oncology, Stanford University School of Medicine, Stanford.; Friedman S; Facing Our Risk of Cancer Empowered, Tampa, USA.; Gelmon KA; Department of Medical Oncology, BC Cancer, Vancouver, Canada.; Gianni L; Department of Oncology, International Breast Cancer Study Group, Bern, Switzerland; Department of Medical Oncology, Ospedale Infermi AUSL della Romagna, Rimini, Italy.; Gnant M; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Hollingsworth SJ; Department of Late Development Oncology, AstraZeneca, Cambridge, UK.; Im SA; Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.; Jager A; Department of Medical Oncology, Dutch Breast Cancer Research Group, Utrecht, the Netherlands.; Jóhannsson ÓÞ; Department of Medical Oncology, Landspítali University Hospital of Iceland, Icelandic Breast Cancer Group, Reykjavik, Iceland.; Lakhani SR; Department of Anatomical Pathology, The University of Queensland Centre for Clinical Research and Pathology Queensland, Brisbane, Australia.; Janni W; Department for Obstetrics and Gynecology, Universitaetsklinikum, University of Ulm, Ulm, Germany.; Linderholm B; Department of Oncology, Sahlgrenska University Hospital, Gothenburg; Department of Oncology, The Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.; Liu TW; Division of Cancer Research, National Health Research Institutes, Taiwan Cooperative Oncology Group, Taipei City, Taiwan.; Loman N; Department of Hematology, Oncology, and Radiation Physics, Swedish Association of Breast Oncologists, Skåne University Hospital, Lund, Sweden.; Korde L; Clinical Investigations Branch, Division of Cancer Treatment and Diagnosis, The National Cancer Institute, Rockville, USA.; Loibl S; Medicine and Research, German Breast Group, Neu-Isenburg; Medicine and Research, The Center for Hematology and Oncology Bethanien and Goethe University, Frankfurt, Germany.; Lucas PC; NRG Oncology/NSABP Foundation, Pittsburgh; Department of Pathology, UPMC Hillman Cancer Center, Pittsburgh, USA.; Marmé F; Medical Faculty Mannheim, Heidelberg University, Mannheim Germany and the German Breast Group, Neu-Isenburg, Germany.; Martinez de Dueñas E; Médica Consorcio Hospitalario Provincial de Castellón, Servicio de Oncología, Castellón, Spain.; McConnell R; Department of Data Management, Frontier Science (Scotland), Kincraig, Scotland, UK.; Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne; Breast Cancer Trials, Australia and New Zealand, Newcastle, Australia.; Piccart M; Department of Scientific Direction, Institut Jules Bordet, l'Université Libre de Bruxelles, Brussels.; Rossi G; Department of Research and Development, Breast International Group, Brussels, Belgium.; Schmutzler R; The Center for Familial Breast and Ovarian Cancer and the Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.; Shao Z; Fudan University Shanghai Cancer Center, Shanghai, China.; Sharma P; Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Westwood, USA.; Singer CF; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Španić T; Department of Patient Advocacy, Europa Donna-The European Breast Cancer Coalition, Milan, Italy; Europa Donna Slovenia, Ljubljana, Slovenia.; Stickeler E; Department of Obstetrics and Gynecology, University Hospital Aachen, Aachen, Germany.; Toi M; Department of Breast Surgery Kyoto University Hospital, Kyoto, Japan.; Traina TA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.; Viale G; Department of Pathology, University of Milan, European Institute of Oncology IRCCS, Milan.; Zoppoli G; Internal Medicine Oncology Unit, Gruppo Oncologico Italiano di Ricerca Clinica, Parma; Università degli Studi di Genova and IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Park YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Yerushalmi R; Department of Oncology, Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petach Tikva; Faculty of Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Yang H; Department of Breast Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou.; Pang D; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.; Jung KH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Mailliez A; Department of Medical Oncology, Breast Cancer Unit, Oscar Lambret Center, Lillie, France.; Fan Z; Department of Breast Surgery, First Hospital of Jilin University, Jilin, China.; Tennevet I; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France.; Zhang J; Breast Cancer Center, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.; Nagy T; Chemotherapy Department B, Országos Onkológiai Intézet, National Institute of Oncology, Budapest, Hungary.; Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Sun Q; Department of Breast Surgery, Peking Union Medical College Hospital, Peking, China.; Parton M; Breast Unit, Royal Marsden Hospital, London, UK.; Colleoni MA; Division of Medical Senology, European Institute of Oncology (IEO), IRCCS, Milan.; Schmidt M; Department of Obstetrics and Gynecology, University Medical Center Mainz, Mainz, Germany.; Brufsky AM; NRG Oncology/NSABP Foundation, Pittsburgh; Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh.; Razaq W; Department of Internal Medicine, Section of Hematology/Oncology, Oklahoma University Health, Oklahoma City, USA.; Kaufman B; The Breast Oncology Institute, Chaim Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.; Cameron D; Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh.; Campbell C; Department of Statistics and Programming, Frontier Science (Scotland), Kincraig, Scotland.; Tutt ANJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London; The Breast Cancer Now Unit, Guy's Hospital Cancer Centre, King's College London, London, UK. Electronic address: andrew.tutt@icr.ac.uk.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Annals of Internal Medicine. 150:19-26
Academic Journal
Solier S; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda (MD), USA.; Zhang YWBallestrero APommier YZoppoli G
Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101094211 Publication Model: Print Cited Medium: Internet ISSN: 1873-5576 (Electronic) Linking ISSN: 15680096 NLM ISO Abbreviation: Curr Cancer Drug Targets Subsets: MEDLINE
Academic Journal
Ballestrero A; Division of Semeiotics and Medical Methodology, Department of Internal Medicine, University of Genoa, Italy. aballestrero@unige.it; Garuti ACirmena GRocco IPalermo CNencioni AScabini SZoppoli GParodi SPatrone F
Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101094211 Publication Model: Print Cited Medium: Internet ISSN: 1873-5576 (Electronic) Linking ISSN: 15680096 NLM ISO Abbreviation: Curr Cancer Drug Targets Subsets: MEDLINE
Academic Journal
Bagnasco L; University of Genoa - Department of Internal Medicine (Di.M.I), Genoa, Italy. luca.bagnasco@unige.it; Piras DParodi SBauer IZoppoli GPatrone FBallestrero A
Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101094211 Publication Model: Print Cited Medium: Internet ISSN: 1873-5576 (Electronic) Linking ISSN: 15680096 NLM ISO Abbreviation: Curr Cancer Drug Targets Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Zoppoli, G
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어